Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 36,650
-150 (-0.41%)
Oct 30, 2026, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 1.62 trillion as of October 30, 2026. It is the 8,942nd most valuable company in the world and the 218th biggest in South Korea. Its market cap has decreased by 41.79% in one year.
Market Cap
1.62T
Enterprise Value
n/a
Revenue
274.73B
Global Rank
Country Rank
#218 South Korea
PE Ratio
62.83
ChartMarket Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 1.62T, an increase of 2,341.50%. That is a compound annual growth rate of 16.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.62T | -37.03% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 5.60T |
| Hanmi Pharm. | 5.16T |
| Hanall Biopharma | 1.89T |
| GC Biopharma | 1.48T |
| Daewoong Pharmaceutical | 1.15T |
| Chong Kun Dang Pharmaceutical | 826.14B |
| Boryung | 698.25B |
| Daewoong | 630.13B |